Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Mol Cancer Res. 2017 Mar 8;15(7):942–952. doi: 10.1158/1541-7786.MCR-16-0408

Table 2.

Multivariate and Univariate Analysis for YTMA 49 and YTMA 201

Multivariate Univariate Multivariate Univariate
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Characteristics
Age at Diagnosis
YTMA 49 YTMA 201

 <50 1 0.100 1 0.5013 1 0.407 1 0.609
 ≥50 1.373 (0.940–2.004) 1.129(0.792–1.610) 1.458(0.592–3.552) 0.820(0.384–1.752)

Tumor Size

 ≤2 cm 1 <0.0001 1 <0.0001 1 0.030 1 0.005
 2–5 cm 3.680 (2.265–5.977) 4.198(2.610–6.753) 2.791 (1.103–7.061) 3.022(1.401–6.522)

Nuclear Grade

 Grade 1 1 0.267 1 0.0089 ------ ------
 Grade 2 1.213(0.863–1.705) 0.642(0.461–0.895)

Nodal Status

 Negative 1 0.0003 1 <0.0001 1 0.006 1 0.002
 Positive 1.967 (1.361–2.843) 2.490 (1.764–35.16) 3.456 (1.420–8.414) 3.815(1.646–8.840)

ER Status

 Negative 1 0.075 1 <0.0001 1 0.532 1 0.061
 Positive 0.719 (0.501–1.033) 0.536 (0.393–0.732) 0.749 (0.303–1.852) 0.492 (0.231–1.003)

PR Status

 Negative 1 0.220 1 0.0004 1 0.370 1 0.147
 Positive 0.813 (0.584–1.132) 0.565 (0.412–0.773) 0.388 (0.049–3.083) 0.228 (0.031–1.680)

HER2 Status

 Negative 1 0.104 1 0.1882 1 0.363 1 0.263
 Positive 1.406 (0.932–2.121) 1.297 (0.881–1.910) 1.597 (0.582–4.379) 1.737 (0.660–4.573)

NCS-1 Expression (Q1–3 vs. Q4)

 Q1–3 1 0.020 1 <0.0001 1 0.004 1 0.004
 Q4 1.532 (1.070–2.193) 2.036 (1.472–2.815) 3.677 (1.509–8.956) 3.008 (1.400–6.327)

HR: Hazard Ratio, CI: Confidence Interval, ER: Estrogen Receptor, PR: Progesterone Receptor, HER2: Human Epidermal Growth Factor Receptor 2, NCS-1: Neuronal Calcium Sensor-1